190 related articles for article (PubMed ID: 9950292)
1. The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 1999 Jan; 16(1):135-40. PubMed ID: 9950292
[TBL] [Abstract][Full Text] [Related]
2. Dependence of the molecular mobility and protein stability of freeze-dried gamma-globulin formulations on the molecular weight of dextran.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 1997 Jun; 14(6):736-41. PubMed ID: 9210190
[TBL] [Abstract][Full Text] [Related]
3. Effect of high molecular mobility of poly(vinyl alcohol) on protein stability of lyophilized gamma-globulin formulations.
Yoshioka S; Aso Y; Nakai Y; Kojima S
J Pharm Sci; 1998 Feb; 87(2):147-51. PubMed ID: 9519145
[TBL] [Abstract][Full Text] [Related]
4. Molecular mobility of protein in lyophilized formulations linked to the molecular mobility of polymer excipients, as determined by high resolution 13C solid-state NMR.
Yoshioka S; Aso Y; Kojima S; Sakurai S; Fujiwara T; Akutsu H
Pharm Res; 1999 Oct; 16(10):1621-5. PubMed ID: 10554107
[TBL] [Abstract][Full Text] [Related]
5. Temperature dependence of bimolecular reactions associated with molecular mobility in lyophilized formulations.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 2000 Aug; 17(8):925-9. PubMed ID: 11028936
[TBL] [Abstract][Full Text] [Related]
6. Molecular mobility of lyophilized poly(vinylpyrrolidone) and methylcellulose as determined by the laboratory and rotating frame spin-lattice relaxation times of 1H and 13C.
Yoshioka S; Aso Y; Kojima S
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1289-92. PubMed ID: 14600374
[TBL] [Abstract][Full Text] [Related]
7. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations.
Yoshioka S; Aso Y
Pharm Res; 2005 Aug; 22(8):1358-64. PubMed ID: 16078146
[TBL] [Abstract][Full Text] [Related]
8. Inactivation and aggregation of beta-galactosidase in lyophilized formulation described by Kohlrausch-Williams-Watts stretched exponential function.
Yoshioka S; Tajima S; Aso Y; Kojima S
Pharm Res; 2003 Oct; 20(10):1655-60. PubMed ID: 14620522
[TBL] [Abstract][Full Text] [Related]
9. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity.
Yoshioka S; Miyazaki T; Aso Y
Pharm Res; 2006 May; 23(5):961-6. PubMed ID: 16715386
[TBL] [Abstract][Full Text] [Related]
10. Effect of polymer excipients on the enzyme activity of lyophilized bilirubin oxidase and beta-galactosidase formulations.
Yoshioka S; Aso Y; Kojima S; Tanimoto T
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):283-5. PubMed ID: 10705520
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the Kohlrausch-Williams-Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 2001 Mar; 18(3):256-60. PubMed ID: 11442261
[TBL] [Abstract][Full Text] [Related]
12. Temperature- and glass transition temperature-dependence of bimolecular reaction rates in lyophilized formulations described by the Adam-Gibbs-Vogel equation.
Yoshioka S; Aso Y; Kojima S
J Pharm Sci; 2004 Apr; 93(4):1062-9. PubMed ID: 14999742
[TBL] [Abstract][Full Text] [Related]
13. Glass transition-related changes in molecular mobility below glass transition temperature of freeze-dried formulations, as measured by dielectric spectroscopy and solid state nuclear magnetic resonance.
Yoshioka S; Aso Y
J Pharm Sci; 2005 Feb; 94(2):275-87. PubMed ID: 15570601
[TBL] [Abstract][Full Text] [Related]
14. Prediction of glass transition temperature of freeze-dried formulations by molecular dynamics simulation.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 2003 Jun; 20(6):873-8. PubMed ID: 12817890
[TBL] [Abstract][Full Text] [Related]
15. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
[TBL] [Abstract][Full Text] [Related]
16. Determination of molecular mobility of lyophilized bovine serum albumin and gamma-globulin by solid-state 1H NMR and relation to aggregation-susceptibility.
Yoshioka S; Aso Y; Kojima S
Pharm Res; 1996 Jun; 13(6):926-30. PubMed ID: 8792434
[TBL] [Abstract][Full Text] [Related]
17. Different molecular motions in lyophilized protein formulations as determined by laboratory and rotating frame spin-lattice relaxation times.
Yoshioka S; Aso Y; Kojima S
J Pharm Sci; 2002 Oct; 91(10):2203-10. PubMed ID: 12226847
[TBL] [Abstract][Full Text] [Related]
18. Softening temperature of lyophilized bovine serum albumin and gamma-globulin as measured by spin-spin relaxation time of protein protons.
Yoshioka S; Aso Y; Kojima S
J Pharm Sci; 1997 Apr; 86(4):470-4. PubMed ID: 9109051
[TBL] [Abstract][Full Text] [Related]
19. Effect of cations and anions on glass transition temperatures in excipient solutions.
Nesarikar VV; Nassar MN
Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
[TBL] [Abstract][Full Text] [Related]
20. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose.
Zeng XM; Martin GP; Marriott C
Int J Pharm; 2001 May; 218(1-2):63-73. PubMed ID: 11337150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
